A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life

NCT00222105 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Doxil
DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]